SJS Investment Consulting’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.99K Buy
183
+181
+9,050% +$6.52K ﹤0.01% 1312
2026
Q1
$71 Buy
+2
New +$81 ﹤0.01% 2192
2025
Q4
Sell
-3
Closed -$142 2100
2025
Q3
$142 Hold
3
﹤0.01% 1539
2025
Q2
$157 Buy
3
+2
+200% +$110 ﹤0.01% 1420
2025
Q1
$61 Buy
+1
New +$64 ﹤0.01% 1549
2024
Q4
Sell
-3
Closed -$216 1627
2024
Q3
$216 Hold
3
﹤0.01% 1495
2024
Q2
$208 Hold
3
﹤0.01% 1504
2024
Q1
$241 Sell
3
-3
-50% -$267 ﹤0.01% 1453
2023
Q4
$658 Buy
6
+1
+20% +$103 ﹤0.01% 1139
2023
Q3
$505 Sell
5
-1
-17% -$115 ﹤0.01% 1212
2023
Q2
$816 Hold
6
﹤0.01% 977
2023
Q1
$624 Buy
6
+1
+20% +$97 ﹤0.01% 1074
2022
Q4
$443 Buy
5
+2
+67% +$166 ﹤0.01% 1258
2022
Q3
$0 Buy
+3
New +$283 ﹤0.01% 1117
2022
Q1
$0 Buy
+1
New +$140 ﹤0.01% 805

Other funds holding CNMD

SJS Investment Consulting's CNMD Position: Q2 2026 in Review

SJS Investment Consulting increased its CONMED (CNMD) stake by 9,050% in Q2 2026, buying an estimated $6.52K and bringing the position to 183 shares worth $5.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

SJS Investment Consulting first reported a position in CNMD in Q1 2022 and has held it in 15 quarters since. 56 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • SJS Investment Consulting held 183 shares of CONMED worth $5.99K as of Q2 2026.
  • SJS Investment Consulting bought 181 CONMED shares in Q2 2026, an estimated $6.52K.
  • CONMED made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1312 holding.
  • SJS Investment Consulting first reported a position in CONMED in Q1 2022 and has held it in 15 quarters since.
  • 56 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.